HF
AMRX icon

HRT Financial’s Amneal Pharmaceuticals AMRX Stock Holding History

HRT Financial’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-102,857
Closed -$1.28M – 4114
2026
Q1 		$1.28M Sell
102,857
-41,785
-29% -$561K ﹤0.01% 1913
2025
Q4 		$1.82M Buy
+144,642
New +$1.65M 0.01% 1368
2025
Q3 		– Sell
-437,330
Closed -$3.54M – 2816
2025
Q2 		$3.54M Buy
+437,330
New +$3.3M 0.02% 679
2024
Q2 		– Sell
-206,012
Closed -$1.25M – 2169
2024
Q1 		$1.25M Buy
+206,012
New +$1.16M 0.01% 780
2023
Q2 		– Sell
-11,811
Closed -$16K – 2417
2023
Q1 		$16K Sell
11,811
-53,543
-82% -$107K ﹤0.01% 2202
2022
Q4 		$130K Buy
+65,354
New +$146K ﹤0.01% 2020
2022
Q3 		– Sell
-261,916
Closed -$832K – 2747
2022
Q2 		$832K Buy
+261,916
New +$949K 0.01% 1070
2022
Q1 		– Sell
-64,148
Closed -$307K – 3042
2021
Q4 		$307K Buy
64,148
+26,215
+69% +$131K ﹤0.01% 2254
2021
Q3 		$202K Buy
+37,933
New +$191K ﹤0.01% 2682
2021
Q1 		– Sell
-38,887
Closed -$177K – 2652
2020
Q4 		$177K Buy
38,887
+13,495
+53% +$59.8K ﹤0.01% 1520
2020
Q3 		$98K Sell
25,392
-20,311
-44% -$86.9K ﹤0.01% 1531
2020
Q2 		$217K Buy
+45,703
New +$188K 0.01% 1126

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

HRT Financial's AMRX Position: Q2 2026 in Review

HRT Financial sold out of Amneal Pharmaceuticals (AMRX) in Q2 2026, closing a stake of 102,857 shares — an estimated $1.28M sold.

HRT Financial first reported a position in AMRX in Q2 2020 and held it in 12 quarters. The position peaked at $3.54M in Q2 2025. 310 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • HRT Financial reported no remaining Amneal Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 102,857 Amneal Pharmaceuticals shares in Q2 2026, an estimated $1.28M.
  • HRT Financial first reported a position in Amneal Pharmaceuticals in Q2 2020 and held it in 12 quarters.
  • HRT Financial's Amneal Pharmaceuticals position peaked at $3.54M in Q2 2025.
  • 310 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.